Shaofei Cheng
222 Huanhu Xi San Road
Pudong, China
Pudong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
B4GALNT4 promotes lung cancer progression by suppressing ferroptosis through glycosylation of SLC7A11.
Journal: Pathology, research and practice
Published: March 05, 2026
Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma.
Journal: Mediators of inflammation
Published: October 18, 2022
UBE4B promotes the development of lung adenocarcinoma by enhancing proliferation, migration and glycolysis via PP2A/AKT signaling.
Journal: Pathology, research and practice
Published: October 26, 2021
SKA3, negatively regulated by miR-128-3p, promotes the progression of non-small-cell lung cancer.
Journal: Personalized medicine
Published: September 17, 2021
Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway.
Journal: Cancer cell international
Published: August 15, 2019
FAM46B suppresses proliferation, migration and invasion of non-small cell lung cancer via β-catenin/MMP7 signaling.
Journal: Translational cancer research
Published: January 30, 2019
Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: December 21, 2018
HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells.
Journal: Cell death & disease
Published: November 14, 2017
Percutaneous cardiopulmonary support for catastrophic pulmonary fat embolism in pigs.
Journal: The journal of trauma and acute care surgery
Published: July 28, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026